Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Avicanna Inc AVCNF


Primary Symbol: T.AVCN

Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including oral, sublingual, topical and transdermal delivery. It has developed a pipeline of patent-pending drug candidates that are indication specific and in various stages of clinical development and commercialization. These cannabinoid-based drug candidates look to address unmet medical needs in the areas of dermatology, chronic pain and various neurological disorders. Its first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America. MyMedi.ca is a medical cannabis care platform that serves medical cannabis patients’ needs and enhances the patient's journey.


TSX:AVCN - Post by User

Comment by Russell1on Jun 29, 2020 10:42am
67 Views
Post# 31202750

RE:RE:RE:RE:RE:RE:RE:RE:Attention

RE:RE:RE:RE:RE:RE:RE:RE:Attention Here is a lesson for you mate...there must be volume on a stock for shorters to be interested. There are plenty of shorters out there and they can damage a stock but that is not the case here unfortunately. Whoever is telling you that is probably the same group of people that told me that Avicanna was going to hit $40 the first week on the market which is why I rushed to buy in above $7. I am confident that there are many other shareholders who have lost their shirt on this stock and that makes it extremely frustrating to see the distraction conversation of shorters and pumpers instead of actually speaking of company fundamentals. Company fundamentals such as how they will pay the bills to keep the company operating, how much more they will have to raise to keep a "scientific approach pharmaceutical" company going because that model is extremely expensive, how will they repay their $5 million loan and how much dilution will current shareholders have to undergo IF Avicanna eventually gets to the finish line. Do your own critical thinking and do not allow the usual digression into pumper/shorter conversations that occurs to distract you from the fundamentals 
<< Previous
Bullboard Posts
Next >>